REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 182 filers reported holding REGENXBIO INC in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,033 | -17.7% | 245 | 0.0% | 0.00% | – |
| Q2 2023 | $4,898 | +24.5% | 245 | +17.8% | 0.00% | – |
| Q1 2023 | $3,933 | -24.9% | 208 | -10.0% | 0.00% | – |
| Q4 2022 | $5,239 | -34.5% | 231 | -21.2% | 0.00% | – |
| Q3 2022 | $8,000 | -38.5% | 293 | -42.2% | 0.00% | – |
| Q2 2022 | $13,000 | -58.1% | 507 | -45.2% | 0.00% | – |
| Q1 2022 | $31,000 | +19.2% | 926 | +18.1% | 0.00% | – |
| Q4 2021 | $26,000 | 0.0% | 784 | +24.4% | 0.00% | – |
| Q3 2021 | $26,000 | +62.5% | 630 | +56.3% | 0.00% | – |
| Q2 2021 | $16,000 | +166.7% | 403 | +117.8% | 0.00% | – |
| Q1 2021 | $6,000 | -25.0% | 185 | 0.0% | 0.00% | – |
| Q4 2020 | $8,000 | +300.0% | 185 | +374.4% | 0.00% | – |
| Q4 2019 | $2,000 | +100.0% | 39 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -66.7% | 39 | -27.8% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 54 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | +50.0% | 54 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -33.3% | 54 | +50.0% | 0.00% | – |
| Q3 2018 | $3,000 | – | 36 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 839,139 | $35,177,000 | 6.39% |
| Sonic Fund II, L.P. | 188,786 | $7,914,000 | 4.47% |
| ArchPoint Investors | 297,355 | $12,465,000 | 3.73% |
| Redmile Group, LLC | 2,008,001 | $84,175,000 | 1.47% |
| RTW INVESTMENTS, LP | 1,845,366 | $77,358,000 | 1.17% |
| WS MANAGEMENT LLLP | 210,729 | $8,834,000 | 0.94% |
| FRAZIER MANAGEMENT LLC | 235,809 | $9,885,000 | 0.79% |
| Integral Health Asset Management, LLC | 55,000 | $2,306,000 | 0.66% |
| Sofinnova Investments, Inc. | 127,593 | $5,349,000 | 0.32% |
| HHLR ADVISORS, LTD. | 456,000 | $19,116,000 | 0.25% |